Literature DB >> 8621

Gastric irritancy of aspirin and its congeners: anti-inflammatory activity without this side-effect.

K D Rainsford, M W Whitehouse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 8621     DOI： 10.1111/j.2042-7158.1976.tb02807.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  9 in total

1.  Comparative Studies of Gastric Ulcerogenesis by Non-steroid Anti-inflammatory Drugs: Effects of Fenclofenac.

Authors:  K D Rainsford
Journal:  Proc R Soc Med       Date:  1977

2.  'Towards assays of gastro-intestinal toxicity of non-steroid anti-inflammatory drugs with improved predictive value in man'.

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1977-07

Review 3.  Gastrointestinal mucosal lesions. A drug formulation problem.

Authors:  O Brors
Journal:  Med Toxicol       Date:  1987 Mar-Apr

4.  A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate).

Authors:  P Schiantarelli; S Cadel; D Acerbi
Journal:  Agents Actions       Date:  1984-02

5.  Structure-activity relationships of non-steroid anti-inflammatory drug 1. Gastric ulcerogenic activity.

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1978-12

6.  Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.

Authors:  Catriona M Turnbull; Clara Cena; Roberta Fruttero; Alberto Gasco; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

7.  Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity.

Authors:  K D Rainsford; M W Whitehouse
Journal:  Agents Actions       Date:  1980-11

8.  Bio-distribution in rats of some salicylates with low gastric ulcerogenicity.

Authors:  K D Rainsford; A Schweitzer; P Green; M W Whitehouse; K Brune
Journal:  Agents Actions       Date:  1980-11

9.  A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.

Authors:  Catriona M Turnbull; Paolo Marcarino; Tara A Sheldrake; Loretta Lazzarato; Clara Cena; Roberta Fruttero; Alberto Gasco; Sarah Fox; Ian L Megson; Adriano G Rossi
Journal:  J Inflamm (Lond)       Date:  2008-07-31       Impact factor: 4.981
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.